HCA Hosts Kidney Disease Roundtable with CMS Administrator Seema Verma
HCA Healthcare recently hosted Centers for Medicare and Medicaid Services Administrator Seema Verma and Deputy Administrator Brad Smith for a roundtable discussion with local health leaders on advancing kidney care. Jonathan Perlin, MD, PhD, president of clinical operations and chief medical officer for HCA Healthcare, moderated the event that coincided with an announcement from CMS regarding a new model of care for Medicare beneficiaries with chronic kidney disease.
HCA Healthcare, one of the nation's largest clinical care providers, was tapped to host the event to continue the ongoing discussion on ways to break down silos between chronic kidney disease, kidney failure and treatment protocols including transplantation. Last year, HCA led the nation in performing 418 live donor kidney transplants. Additionally, the health system was responsible for 652 deceased donor transplants, which is more than 7 percent of the kidneys recovered nationwide.
While there have been advances over the last few years, Perlin said clinicians and organizations across the country that work with patients with end-stage renal disease (ESRD) know more can and should be done. "There are too many at-risk patients who progress to late-stage kidney failure; mortality rate is too high; treatment options are expensive, and the quality of life is simply too low," he stated, adding there are not enough kidneys donated to meet the need.
"Kidney disease is a major, prominent, prevalent condition," Perlin continued. "It's the ninth leading cause of death in the United States." He added 37 million American live with kidney disease and more than 726,000 progress to ESRD. Annually, more than 100,000 Americans begin dialysis with 20 percent dying within a year and 50 percent dying within five years. Currently, nearly 100,000 Americans are awaiting transplant. Unfortunately, on average, 13 people a day die before a kidney becomes available.
In introducing the new model of care, Verma said that while the emphasis is on finding ways to make healthcare more affordable and accessible, the structure of various government programs can sometimes create misaligned incentives. "In Medicare, in particular with our ESRD program, that's exactly what we've seen," Verma continued. "And so, we've been really focused over the last year - based on the president's executive order - to try to specifically improve the lives of people with kidney disease."
As a result, CMS announced finalization of the End-Stage Renal Disease Treatment Choices (ETC) Model on Sept. 18 to transform chronic kidney care for Medicare beneficiaries. Building off President Donald Trump's Advancing Kidney Health Executive Order, the ETC model encourages increased use of home dialysis and kidney transplants.
Verma noted traveling to a hemodialysis center not only eats up a large portion of the day but also potentially exposes ESRD patients to other health threats, including COVID-19. Verma noted Medicare beneficiaries with ESRD who contract the coronavirus have higher rates of hospitalization. With home dialysis, patients are able to shelter in place during the public health crisis while still receiving the care they need.
"The model today is part of a larger effort to improve the health, in general, of people living with kidney disease," Verma said. While the ETC program creates a new payment model, she said the agency has also been focused on improving organ procurement. "The idea here is to make sure that we're doing everything we can to increase the transplantation rate," she said.
Brad Smith, a Nashville healthcare entrepreneur who was tapped to lead the CMS Innovation Center at the beginning of this year, drilled down on the ETC model. Smith noted the work was very personal for him, as he had a cousin who had been on dialysis for several years before passing away at the age of 28.
Smith said CMS has been looking at the way kidney care is delivered in the United States, focusing on three key areas: in-home dialysis, transplant rate, and the impact of the pandemic on ESRD patients.
Provider Thoughts on Advancing Kidney Care
Seth Karp, MD, FACS, director of the Vanderbilt Transplant Center, was one of the local health leaders in attendance at the CMS briefing hosted by HCA Healthcare.
Karp, who is the H. William Scott, Jr. Chair in Surgery and surgeon-in-chief for Vanderbilt University Medical Center, said he believes the new incentives and increased attention on kidney disease will improve patient health and provide a better quality of care.
"I'm particularly excited about the OPO (Organ Procurement Organizations) reform measures that are coming through. I think that's going to make an enormous difference in the number of kidneys we have to transplant," he said.
Karp noted Vanderbilt is one of the largest transplant centers in the country and said they were on track to perform close to 300 kidney transplants this year, with about 80 of those being from living donors. He added the move to use organs donated from Hepatitis C patients has increased access tremendously. "It's made a huge difference. We're able to treat patients for Hepatitis C after the transplant," Karp said, pointing to the advent of highly effective direct-acting antiviral therapeutics that are now widely available.
For patients in need of dialysis, Karp agreed with the general push toward in-home care. "While the transplant center doesn't control location of dialysis treatment, we recommend in-home dialysis for our patients who can tolerate it," he said. "Travel for a lot of our patients, especially rural patients, is very difficult; and so, the more we can bring services to them in their homes, the better off they are."
Looking at home dialysis rates, Smith said about 12 percent of patients in the U.S. get in-home dialysis. "But when you compare that across the world, that's a pretty low rate - so in the U.K., it's about 18 percent, and Canada is about 25 percent," he said. Smith added that although only 12 percent nationally are doing dialysis at home, 85 percent of individuals are actually eligible for that treatment option.
"The second piece is when you look at our transplant rate," Smith continued. "Of the 61 more developed countries, we're actually 39th in terms of transplant rate. Only 2.9 percent of patients actually are able to receive a transplant before they go on dialysis, and only about 30 percent of those with ESRD actually have had a transplant, so we feel like there's a tremendous opportunity to change how we deliver care in this country around end-stage renal disease."
When it comes to COVID, Smith said, "Our ESRD patients are one of our highest risk groups across the entire country. If you get COVID and you have ESRD, you're eight times more likely to pass away than the average American."
To address these issues, the Center for Medicare and Medicaid Innovation (CMMI) has been working on payment transformation over the past five years, staring in 2015 with the comprehensive End-Stage Renal Disease Model with 37 groups taking full capitated risk for their dialysis beneficiaries. "We've seen really good results in that model. Hospitalizations have come down; emergency dialysis treatments have gone down; readmissions have gone down," he said. While the quality of care increased, Smith said CMS didn't see the anticipated savings from the program. "Part of the reason for that is really we were starting too late, and we were only starting with patients once they reached dialysis."
New models being rolled out in 2021 focus on patients in stage 4 and 5 of chronic disease before they advance to ESRD. "That's a time when we believe we can have the biggest impact," he said.
A second lesson from the earlier model was the needle didn't move on in-home dialysis or kidney transplant, which is why the new ETC model increases reimbursement for in-home dialysis claims. "In the first year, we'll increase them by 3 percent, then 2 percent, then 1 percent in the third year," Smith said.
"In addition, and probably even more importantly, we're putting in place an incentive structure for nephrologists and for ESRD facilities around in-home dialysis and transplants," he continued. Smith explained each year the percentage of patients who either get in-home dialysis, are on the wait list for transplant or who receive living-donor transplant will be calculated for each practice or clinician. "And then based on that, it will make an adjustment to their Medicare claims. In the first year that could be as much as +4 or -5, and in the last year, year five, that could be as much as +8 or -10," he said.
This demonstration model will roll out to about 30 percent of the country this coming January. The hope is to improve quality, give providers and centers more flexibility and save an estimated $23 million through the program.
However, Smith stressed the savings component isn't the main driver. "The main goal of the model is to make sure that folks can have the choices that they want and hopefully that we can altogether ... along with all the other rules that we're reviewing and regulations we're rolling out ... increase the number of transplants that are happening across the country."
Ascension Saint Thomas West Marks 100th YTD Kidney Transplant
In early October, leaders from the Kidney Transplant Program at Ascension Saint Thomas West marked their program's record-breaking 100th kidney transplant year-to-date.
"We have been blessed and successful in our endeavors because we continue to be a very patient-centric program concentrated on the needs of every individual patient no matter what their insurance or social status," said Kidney Transplant Program Director Derek Moore, MD. "We continue to revise our evaluation and surgical techniques to deal with and operate on patients whom others have not agreed to operate on."
Laurie Oliver, director of the Ascension Saint Thomas Heart and Kidney Transplant Programs, said the health system has seen expansion in the kidney transplant program over the past four years, having grown over 70 percent since 2016. Earlier this year, Ascension Saint Thomas West and Nephrology Associates announced an exclusive collaboration to expand kidney transplant care.
Monogram Health Earns NCQA Accreditation
Nashville-based Monogram Health, a managed services company focused on kidney disease, has received Population Health Program accreditation from NCQA.
Monogram uses proprietary artificial intelligence systems to identify the potential care needs of patients with kidney disease. The company's care team - made up of nurse care managers and social workers - partners with nephrologists to ensure medication and treatment compliance and adherence to evidence-based care pathways. The specialized care team also assesses health drivers, such as appropriate nutrition, exercise and other social determinants of health, through regular visits with patients in their homes.